U.S. Retail REITs Stock News

Eton Pharmaceuticals has turned heads with a very large 3 year return and a fresh 52 week run, yet its current checks paint a picture of a stock that screens as expensive rather than a clear bargain. Over the past 3 years, Eton Pharmaceuticals has delivered a very large total return of about 13x. This puts extra focus on whether recent optimism has already been reflected in the share price. Recent momentum around a new FDA approved drug agreement can support expectations for future revenue...

Digital Turbine stock has rebounded strongly in the short term, yet the valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to a premium while market multiples suggest the shares may be on the cheap side. Over the past 5 years the share price has declined about 86.9%, which leaves recent gains set against a much weaker longer term record for investors who held through the period. Expectations for Digital Turbine to sustain and convert its revenue...

Cleveland-Cliffs stock is coming off a difficult stretch, with the share price down 57.0% over the past 5 years, yet both the intrinsic value estimate using a Discounted Cash Flow (DCF) approach and conventional market multiples currently point to the shares trading below what the underlying cash flows may justify. The 57.0% share price decline over 5 years leaves existing holders with a steep loss, while raising the question of whether expectations have swung too far to the pessimistic...

CAVA Group stock has given investors a solid 41.1% gain over the past three years, yet the latest valuation checks and recent share price pullback raise questions about whether the current level still makes sense or now leans expensive. Over the past three years, CAVA Group has returned 41.1%. This puts the recent share price weakness into context as a pause after a stronger multi year run. The planned expansion of the restaurant base can support higher revenue expectations over time. The...

WaFd (WAFD) has put up a clean set of Q3 2026 numbers, with total revenue of about US$194.5 million and basic EPS of roughly US$0.85 feeding into trailing 12 month revenue of about US$761.1 million and EPS of around US$3.17. The company has seen revenue move from about US$721.1 million on a trailing basis in Q3 2025 to roughly US$761.1 million by Q3 2026, while trailing EPS shifted from about US$2.62 to US$3.17, setting the backdrop for investors weighing slower top line growth against firmer...

nLIGHT’s stock has delivered very strong gains over the past few years, yet the latest valuation checks, including an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples, both point to the shares trading at a premium to those fundamentals. Over the last 3 years, nLIGHT has returned about 376.6%, which puts extra focus on whether recent gains are already pricing in much of its future potential. The recent award of a Pentagon contract with funding...

Merit Medical Systems stock has delivered a modest 15.2% gain over the past five years, and today its valuation signals are split. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while earnings-based multiples suggest the shares trade at a premium. That tension leaves investors weighing a DCF view that screens the stock as undervalued against a market multiple read that looks less forgiving. Over five years, Merit Medical Systems has returned 15.2%, which...

Leadership transition at Napco Security Technologies Napco Security Technologies (NSSC) has announced a leadership transition that shifts founder Richard Soloway from Chief Executive Officer to Founder and Executive Chairman, while long-time executive Kevin Buchel steps into the Chief Executive Officer and President roles. For investors watching Napco Security Technologies stock, the move concentrates day-to-day operational responsibility with Buchel, who has more than 25 years of experience...

Happen (HAPN) is drawing investor interest after recent share price moves, with the stock down about 2% on the day and around 5% over the past week, despite modest gains over the past month. See our latest analysis for Happen. Set against a 1 year total shareholder return of 47.47% and a 3 year total shareholder return of 88.16%, Happen's recent 7 day share price decline of 5.50% suggests momentum has cooled in the short term, while longer term holders remain ahead. If Happen's swings have...

Public Service Enterprise Group stock sits at an interesting point where a 51.8% gain over the past five years meets a current valuation picture that looks roughly in line with an intrinsic value estimate from a Dividend Discount Model (DDM). At the same time, market multiples still lean toward the shares screening as undervalued. Over the past 5 years, Public Service Enterprise Group has returned 51.8%, which suggests long term holders have been rewarded even though the stock has been...

Rayonier (NYSE:RYN) has appointed Ryan Daniels as Senior Vice President, Wood Products. Daniels steps into the permanent role after serving as Interim SVP, Wood Products. He previously held operational roles at PotlatchDeltic before its recent merger with Rayonier. Rayonier, trading at about $21.8 per share, is in the middle of integrating its wood products operations following its merger with PotlatchDeltic. The appointment of Ryan Daniels formalizes leadership over one of the company’s...

After a strong three year gain of 107.1%, Hanover Insurance Group no longer looks obviously cheap, and the current checks point to a stock that is priced roughly in line with its fundamentals rather than at a clear bargain. Over the past 3 years, Hanover Insurance Group has returned 107.1%, which puts extra attention on whether recent share price strength is already baking in much of the good news. The recently announced CEO succession plan can support confidence in continuity and execution...

Catalyst Pharmaceuticals stock has delivered a very large 5 year return, yet the latest valuation checks suggest the current price looks roughly in line with what the broader fundamentals support rather than clearly cheap or clearly stretched. Over the past 5 years, Catalyst Pharmaceuticals has returned about 4.6x, which puts extra focus on whether the recent share price now simply reflects the progress already made. The agreed acquisition by Angelini Pharma can support confidence in the...

Brookdale Senior Living Inc. recently reported that for June 2026 its consolidated weighted average occupancy rose to 82.5%, with both month‑end and same‑community measures improving year over year and sequentially. Alongside this operational progress, Brookdale refinanced part of its 2027 debt, extended its revolving credit facility, and acquired the Brookdale Galleria community in Houston using cash and its expanded credit line. We’ll now examine how Brookdale’s improved occupancy and...

Public Storage (PSA) has been in focus after a 3.04% stock move, which has been linked to lower Treasury yields and increased demand for dividend income, along with a recent change in its senior leadership team. See our latest analysis for Public Storage. At a share price of $318.04, Public Storage has given investors a year to date share price return of 23.06%, while its 1 year total shareholder return of 16.61% and 5 year total shareholder return of 26.17% point to steadier long term...

Nuclear energy stocks are drawing fresh attention as investors weigh mixed inflation signals, shifting rate expectations, and energy costs that continue to ripple through global markets. With central banks reacting to stubborn price pressures and geopolitical tensions influencing fuel and power expenses, some investors are looking at nuclear power as one potential source of reliable, low carbon electricity within the broader energy mix. This Nuclear Energy Stocks screener highlights companies...

Motorola Solutions stock sits at an interesting point where a near doubling in total return over the past five years meets valuation checks that suggest it is no longer an obvious bargain, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to roughly fair pricing while market multiples lean expensive. Over five years, Motorola Solutions has delivered a total return of 97.8%, which puts recent pricing in the context of a long and substantial move. Ongoing demand for mission...

Recent commentary on WillScot Holdings highlights past declines in sales and returns on capital, alongside a downward trend in earnings per share that has raised questions about the company’s longer-term growth prospects. The comparison with peers such as APi and Intuitive Surgical, which are currently generating stronger revenue and earnings performance, has sharpened investor focus on WillScot’s operational and capital allocation challenges. We’ll now examine how concerns over shrinking...

Bank7 (BSVN) has just posted Q2 2026 results, with total revenue of US$22.9 million and basic EPS of US$0.88, set against trailing 12 month revenue of US$97.7 million and EPS of US$4.43 that frame the latest quarter within a steady recent earnings run. Over the last few quarters, revenue has moved between US$22.6 million and US$26.2 million while quarterly EPS has ranged from US$0.88 to US$1.27. This gives investors a clear view of how the current print fits into the recent trend before...

Skyworks Solutions (SWKS) is back in focus as investors weigh upbeat commentary about a possible earnings beat against fresh concerns over margin pressures, customer concentration risks, and a recent analyst downgrade. See our latest analysis for Skyworks Solutions. At a share price of US$59.35, Skyworks Solutions has seen short term momentum soften, with a 30 day share price return down 14.46%, a 1 year total shareholder return down 15.01%, and a 5 year total shareholder return down 64.42%...

In July 2026, WD-40 Company reported third-quarter results showing sales of US$195.12 million and net income of US$30.22 million, alongside continued progress on its share repurchase program that has retired 193,425 shares for US$42.94 million since July 2023. Despite higher nine-month sales of US$511.21 million, net income over the same period edged lower to US$67.99 million, highlighting how rising costs and margin pressure are tempering the benefits of revenue growth. With third-quarter...

Kimberly-Clark (KMB) is in focus after Arbex, its joint venture with Suzano, began operating as an independent tissue and hygiene company serving more than 70 markets worldwide, raising fresh questions for investors. See our latest analysis for Kimberly-Clark. At a share price of $108.35, Kimberly-Clark has seen its 30-day share price return of 6.78% and 90-day share price return of 9.62% contrast with a 1-year total shareholder return that is down 10.88%. This suggests recent momentum has...

Bio-Techne (TECH) stock is in focus after the company reported a softer quarter, with revenue down 1.5% year on year and below analyst expectations, yet the share price has since risen 26.1%. See our latest analysis for Bio-Techne. Over the past month, Bio-Techne’s 31.1% share price return suggests momentum has picked up again. The 39.5% total shareholder return over one year contrasts with weaker total shareholder returns over three and five years, which hints at a recent shift in...

The Fed’s push for a smaller balance sheet, less explicit guidance, and tighter liquidity rules is reshaping the backdrop for large financial stocks. When central bank support steps back, the companies most tied to market-making, lending, and asset management can see funding conditions, trading activity, and fee pools shift in unpredictable ways. This article looks at 3 stocks that appear more exposed to potential downside from these policy changes. By understanding how the news ties into...